Baxter price target raised to $50 from $45 at TD Cowen

TD Cowen raised the firm’s price target on Baxter to $50 from $45 and keeps an Outperform rating on the shares. The analyst said they had a decent start to 2023 with 1Q revenue and EPS that beat Street forecasts. For the full year the company reiterated its reported revenue guidance modestly increased its CC revenue guidance.